登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>TIGIT >EP-131

TIGIT : CD155 [Biotinylated] Inhibitor Screening ELISA Kit

For research use only.

IDComponentsSize
EP131-C01High-bind Plate1plate
EP131-C02Human TIGIT10μg
EP131-C03Biotinylated Human CD15535μg
EP131-C04Anti-TIGIT Neutralizing Antibody20μg
EP131-C05Streptavidin-HRP10μg
EP131-C06Coating Buffer12mL
EP131-C0710xWashing Buffer 50mL
EP131-C08Blocking Buffer50mL
EP131-C09Substrate Solution12mL
EP131-C10Stop Solution7mL

背景(Background)

CD155 and ITIM domains (TIGIT) is a novel type of immune checkpoint. CD155 is an adhesion molecule that is upregulated during tumor progression and promotes the proliferative and migratory abilities of tumor cells via various pathways. TIGIT, an inhibitory receptor, is mainly expressed on natural killer (NK), CD8+ T, CD4+ T and T regulatory (Treg) cells. CD155 transmits immune signals via interacting with the inhibitory checkpoint receptor TIGIT, thereby inhibiting the function of T and NK cells.CD155 is highly expressed on the surface of DC cells. When TIGIT on T cells binds to CD155 on DC cells, CD155 will send signals to DC cells to up-regulate the secretion of IL-10 and down-regulate the secretion of IL-12, thereby weakening the immune response mediated by DC cells. DC cells are important antigen-presenting cells in the body, and reduced DC cell activity in turn reduces T cell activity.

应用说明(Application)

This kit is developed for screening for inhibitors of human TIGIT binding to human CD155.

It is for research use only.

重构方法(Reconstitution)

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储(Storage)

Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

原理(Assay Principles)

This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new TIGIT pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human CD155 to immobilized human TIGIT in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated CD155 protein, a human TIGIT protein, an anti-TIGIT neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human TIGIT.

b) Add your molecule of interest to the tests.

c) Add human CD155-Biotin to bind the coated human TIGIT.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

Finally, the half maximal inhibitory concentration (IC50) of your compound to TIGIT: CD155 binding will be determined by comparing OD readings among different experimental groups.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

TIGIT TYPICAL DATA

INHIBITION OF TIGIT: CD155 [BIOTINYLATED] BINDING BY ANTI-TIGIT NEUTRALIZING ANTIBODY
Serial dilutions of Anti-TIGIT Neutralizing antibody (Catalog # EP131-C04) (1:1 serial dilution, from 5 μg/mL to 0.01μg/mL) was added into TIGIT: Biotinylated CD155 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
TIGIT靶点信息
英文全称:T cell immunoglobulin and ITIM domains
中文全称:T细胞免疫球蛋白ITIM结构域
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:39详情
最高研发阶段:临床三期
查看更多信息
前沿进展
点击查看详细
相关产品
View All TIGIT

消息提示

请输入您的联系方式,再点击提交!

确定